EnerSpar Corp. (TSE:NRX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NurExone Biologic Inc. is showcasing its innovative ExoPTEN therapy, aimed at treating acute spinal cord injuries, at two prestigious September conferences. The company’s CEO will present their research in Boston and participate as a panelist in New York, signifying NurExone’s growing impact in regenerative medicine and exosome technology.
For further insights into TSE:NRX stock, check out TipRanks’ Stock Analysis page.